Corticosteroid Against Saline Injections for Thumb Osteoarthritis (CASITOA)

Recruiting Phase 2 Interventional Study
Trapeziometacarpal Osteoarthritis
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Prior Safety Data This treatment has already been tested in at least one earlier human trial.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Trial phase
Phase 2
Study type
Interventional
Purpose
Treatment
Participants needed
40 (estimated)
Sponsor
Université du Québec à Trois-Rivières · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Thumb osteoarthritis or trapeziometacarpal osteoarthritis (TMO) is a common and painful form of hand arthritis that limits thumb mobility and hand function, affecting patients' quality of life. Although corticosteroids injections are a typical treatment, their effectiveness has been challenged, and side effects have been reported. Recent studies suggest that saline injections, usually considered i…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * aged ≥18 years; * diagnosis of TMO was confirmed by X-ray interpreted by a radiologist; * suffering from pain at the base of the thumb; * the attending physician deems that an intra-articular corticosteroid injection would be beneficial, rather than opting for other types of i…
Contacts

Tokiko Hamasaki, PhD

819-478-5011

tokiko.hamasaki@uqtr.ca

CONTACT

Carlos Gevers-Montoro, PhD

819-979-0448

carlos.geversmontoro@mcgill.ca

CONTACT